AccessLifeNetHealth

Phone: 888.847.7831

Focus on Safety

LIFELINES Newsletter
Subscribe
In This Issue

Focus on Safety: LifeNet Health Follows Stringent AAMI Guidelines on Sterility

Focus on Quality: Peroneus Longus and Posterior Tibialis Bio-Implants in Knee Reconstruction

Focus on Innovation: LifeNet Health Introduces New Product: Oracell™ Decellularized Dermis for Dental and Maxillofacial Applications available November 1, 2010

Focus on Service: CEU Program for Burn Applications Now Available

Upcoming Events

The American Academy of Periodontology Annual Meeting
10/30/10 — 11/2/10
Honolulu, HI

Northeast Region Burn Conference
10/14/10 - 10/15/10
San Francisco, CA

Southern Thoracic Surgical Association Annual Meeting
11/7/10 —11/10/10
Bonita Springs, FL

Southern Region Burn Conference 11/11/10 —11/17/10
Memphis, TN

Allograft Bio-Implants: Commitment To Quality Facility Tour CEU Program (6 credits)
11/19/10
LifeNet Health Virginia Beach, VA

Focus on Safety:
LifeNet Health Follows Stringent AAMI Guidelines on Sterility


Sterility is defined as the complete absence of living microorganisms. Since proving complete freedom from contamination on each individual graft is not feasible, the likelihood of a product being sterile is expressed in terms of the probability of a microorganism surviving a sterilization process. The Sterility Assurance Level (or SAL) of a product is defined as the probability of any given unit being non-sterile after exposure to a validated sterilization process. SAL is, therefore, a measure of confidence in the attainment of sterility.

In guidelines set forth by the Association for the Advancement of Medical Instrumentation (AAMI), invasive and surgically implantved medical devices should have a Sterility Assurance Level of at least 10-6. The United States Pharmacopeia (USP) establishes in their standards that a sterility assurance level (SAL) of 10-3 is comparable to the microbial survivor probability of aseptically produced products and is a level similar to the overall efficiency of an aseptic operation. Whereas a 10-3 SAL provides a probability of one viable microorganism in a thousand units, products with a 10-6 SAL will have no more than a single viable particle in a million units. Consequently, the lower the SAL, the greater is the assurance of sterility.

Although current regulations do not require tissue banks to use processing methods that guarantee tissue sterility, LifeNet Health has adopted the stringent AAMI guidelines recommending a Sterility Assurance Level of at least 10-6.

Numerous sterilants and sterilant combinations are used to eradicate microorganisms on allograft tissues. These include chemical sterilants, gas plasma, ethylene oxide (EO), gamma radiation, and e-beam radiation. Sterilization systems such as LifeNet Health’s Allowash XG®, which utilizes a controlled-dose, low-temperature gamma irradiation approach to eradicate microbes and viruses while preserving biomechanical integrity and function of allograft tissue necessary for surgical applications.

For more information on the Allowash XG process, please click here.



©2010 LifeNet Health, Inc. All rights reserved.

 

 


LifeLines Newsletter

Links to our Newsletter Archive Focus on SafetyDecember 2011
Focus on SafetyFocus on Safety
Focus On Safety
Issue 019Issue 019
Focus on QualityFocus on Quality
Focus on QualityDecember 2011
Focus on InnovationDecember 2011
Focus on InnovationFocus on Innovation
Issue 018December 2011
Focus on ServiceFocus on Service













  1. Enter the text as it appears on the image

X